Skip to main content

Table 2 Calculated molecular profile for compound 13

From: Design and synthesis of new 1,2,3-triazole-methoxyphenyl-1,3,4-oxadiazole derivatives: selective butyrylcholinesterase inhibitors against Alzheimer’s disease

Compound 6

Descriptor

Mw

LogP

H-bond

Acceptor

H-Bond

Donor

BBB

Human intestinal absorption (%)

13a

409.449

4.622

7

0

1.138

98.537

13b

454.446

4.531

9

0

0.249

100

13c

427.439

4.761

7

0

1.417

98.553

13d

439.475

4.631

8

0

0.906

99.556

13e

427.439

4.761

7

0

1.362

97.989

13f

445.429

4.901

7

0

1.65666

98.051

13 g

457.465

4.770

8

0

1.087

99.055

13 h

443.894

5.276

7

0

1.607

97.087

13i

488.891

5.184

9

0

0.417

1.00

13j

461.884

5.415

7

0

1.917

97.086

13k

473.92

5.284

8

0

1.417

98.089

13 L

488.345

5.385

7

0

1.635

97.02

13 m

533.342

5.293

9

0

0.445

100

13n

506.335

5.524

7

0

1.944

97.019

13o

518.371

5.393

8

0

1.758

98.022

13p

472.436

4.670

9

0

0.294

100

13q

423.476

4.931

7

0

1.337

98.546

13r

441.466

5.070

7

0

1.621

98.236

13s

468.473

4.839

9

0

0.352

100

13t

453.502

4.939

8

0

1.182

99.643